Form 4 for LGVN Longeveron Inc.

Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001214659-22-007228 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-05-19	2022-05-17	LGVN	Soffer Donald M	Dir	J - Other	$0.00	-7.02M	0	-100%	$0
	2022-05-19	2022-05-17	LGVN	Soffer Donald M	Dir	J - Other	$0.00	+6.54M	6.69M	+4,123%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-17	J	D	7,024,208	$0.00	0	I Held by affiliate entity	—	—	(F1) Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. (F2) Shares distributed on pro rated basis to members of DS Med, LLC, for no consideration.
2	Common	Common Stock	2022-05-17	J	A	6,535,223	$0.00	6,693,737	D	—	—	(F1) Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. (F3) Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration. (F4) Amount includes 6,535,223 shares of Class B Common Stock.